Nalls Sherbakoff Group, LLC Calliditas Therapeutics Ab Transaction History

Nalls Sherbakoff Group, LLC

  • $112 Billion
  • Q4 2023

A detailed history of Nalls Sherbakoff Group, LLC transactions in Calliditas Therapeutics Ab stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 18 shares of CALT stock, worth $720. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18
Previous 35 48.57%
Holding current value
$720
Previous $640,000 27.5%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Apr 09, 2024
SELL
$15.79 - $28.99 $268 - $492
-17 Reduced 48.57%
18 $464,000
Q1 2023

Oct 17, 2023
BUY
$16.8 - $25.24 $588 - $883
35 New
35 $808,000

Others Institutions Holding CALT

# of Institutions
4
Shares Held
4.17K
Call Options Held
0
Put Options Held
0
View Full List

About Calliditas Therapeutics AB

CALT Quotes by TradingView
  • Ticker CALT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,624,800
  • Market Cap $1.06B
  • Description
  • Calliditas Therapeutics AB (publ), a clinical-stage biopharmaceutical company, focused on identifying, developing, and commercializing pharmaceuticals products for treatments in orphan indications with initial focus on renal and hepatic diseases. It offers Nefecon, an oral formulation of budesonide that is an immunosuppressant for the treatment ...
More about CALT
Track This Portfolio

Track Nalls Sherbakoff Group, LLC Portfolio

Follow Nalls Sherbakoff Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nalls Sherbakoff Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nalls Sherbakoff Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email